Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Shares Repurchased: 2019-2024

Historic Shares Repurchased for C4 Therapeutics (CCCC) over the last 4 years, with Dec 2024 value amounting to $194,000.

  • C4 Therapeutics' Shares Repurchased fell 71.76% to $24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $373,000, marking a year-over-year increase of 22.70%. This contributed to the annual value of $194,000 for FY2024, which is 76.36% up from last year.
  • C4 Therapeutics' Shares Repurchased amounted to $194,000 in FY2024, which was up 76.36% from $110,000 recorded in FY2023.
  • In the past 5 years, C4 Therapeutics' Shares Repurchased ranged from a high of $194,000 in FY2020 and a low of $110,000 during FY2023.
  • Its 2-year average for Shares Repurchased is $152,000, with a median of $152,000 in 2023.
  • Data for C4 Therapeutics' Shares Repurchased shows a peak YoY spiked of 546.67% (in 2020) over the last 5 years.
  • Over the past 3 years, C4 Therapeutics' Shares Repurchased (Yearly) stood at $194,000 in 2020, then reached $110,000 in 2023, then surged by 76.36% to $194,000 in 2024.